Clear Complexion moisturizer: cream-like texture and a lotion label

The manufacturer’s page names Positively Radiant Clear Complexion Daily Acne Facial Moisturizer and states salicylic acid 0.5%. The Kenvue label identifies Clear Complexion Daily Moisturizer as an acne medication. These records provide a specific subject, rather than evidence about every Aveeno soy product or facial moisturizer. Manufacturer identity and acne label.

The collection name alone is less precise than that full description. Keeping it intact helps prevent neighboring products from supplying missing ingredients or outcomes. The product-version guide explains why this matters. The review concerns the named US records; no physical container, international version or personally experienced effect was examined as part of this document reading.

The website uses rich cream as a texture heading and later describes the product as light yet creamy. It also calls the item a facial moisturizer lotion. The structured label identifies salicylic acid lotion, with a moisturizer name on the package panel. Those details should be read together rather than selecting the word that best fits a cream search. Texture descriptions and lotion record.

Texture wording does not establish another formulation or a comparative comfort result. The format comparison provides a useful place to consider how search categories differ from product identities. Here, a lotion can have a cream-like description without being rewritten as a separate cream preparation or ranked against a wash.

The acne record states salicylic acid 0.5% and presents a complete inactive list. Among its components are glycerin, dimethicone, soybean seed extract and fragrance. Those named ingredients provide more specific formula information than the short website emphasis on tone-correcting soy. Active and inactive record.

The declaration does not give every inactive concentration or show how an individual will tolerate the mixture. Neither should a headline percentage be used to calculate equivalent performance against another product. The strength discussion examines that general limitation. This record identifies the stated ingredients while leaving a full outcome comparison and an assessment of the actual supplied item outside the review’s findings.

Aveeno describes soy in terms of radiance, skin tone and texture. The page discusses several kinds of soy constituents in general, while the acne label specifically names soybean seed extract in its ingredient record and an acne-management Use. These are useful but different descriptions. Soy narrative and label purpose.

The general narrative does not identify every soy constituent or concentration in the finished lotion. It also does not provide a measured pore endpoint for this preparation. Keeping appearance language apart from acne-label Uses avoids assigning one result to another question. The Clearasil record review is another place to examine how a benefit headline and a label describe different evidence roles.

The label was updated April 10, 2025 and identifies Kenvue Brands LLC. Its panel names a 4 fl oz, 118 mL moisturizer. The NDC helps locate this particular record; it does not establish the manufacturing date or the package a retailer will currently fulfill. Dated package record.

FDA explicitly distinguishes an NDC listing from approval or verification of submitted product information. FDA identifier explanation. Applying that distinction keeps an accessible label from becoming a seal of clinical quality. No checkout, inventory or supplied bottle was verified here. The useful fact is the exact label version and its package description, with those remaining transaction questions left open.

The website includes hypoallergenic wording in its care-for-skin section. The label also contains warnings about dryness and irritation and includes fragrance in its inactive declaration. These statements can coexist in the record; the reassuring descriptor does not erase the more specific warning or guarantee that a person cannot react. Website positioning and label warning.

The ingredient list alone likewise cannot prove that a particular component caused a symptom. This review does not diagnose a reaction or recommend a replacement. The Obagi toner review offers a further discussion of keeping product-family descriptions attached to the correct formula. Neither comparison establishes which preparation an individual would find more comfortable.

The reviewed documents establish the moisturizer’s named form, active declaration, inactive list and appearance positioning. They do not provide a full product-specific study that settles personal comfort or a comparative result. The remaining question should name this exact lotion and the outcome of interest, rather than assume that creamy or hypoallergenic words answer it. Product record and warnings.

FDA’s Drug Facts explanation treats warnings and Uses as distinct fields. Label-reading context. That framework helps retain both the advertised role and its limits. No transaction was tested, and bottle contents are not converted into treatment duration. A clearer document can support a more precise question without supplying personal instructions, an efficacy score or a clinical endorsement.